RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000068.xml
Semin intervent Radiol 2011; 28(2): 202-206
DOI: 10.1055/s-0031-1280665
© Thieme Medical Publishers
DOI: 10.1055/s-0031-1280665
Nontarget Embolization Complicating Transarterial Chemoembolization in a Patient with Hepatocellular Carcinoma
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
16. Juni 2011 (online)
ABSTRACT
Nontarget embolization during transarterial chemoembolization, although infrequent, can be a serious complication. The authors describe a case of nontarget gastric embolization to the stomach after transarterial chemoembolization and describe the published incidence of nontarget embolization to various organs, its diagnosis, treatment, and possible outcomes.
KEYWORDS
Chemoembolization - hepatocellular carcinoma
REFERENCES
- 1 Cammà C, Schepis F, Orlando A et al.. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002; 224 (1) 47-54
- 2 Brown D B, Fundakowski C E, Lisker-Melman M et al.. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2004; 15 (11) 1209-1218
- 3 Gates J, Hartnell G G, Stuart K E, Clouse M E. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics. 1999; 19 (2) 399-414
- 4 López-Benítez R, Radeleff B A, Barragán-Campos H M et al.. Acute pancreatitis after embolization of liver tumors: frequency and associated risk factors. Pancreatology. 2007; 7 (1) 53-62
- 5 Su Y C, Chen L T, Jan C M et al.. Reappraisal of gastroduodenal lesions after transcatheter arterial chemoembolization of liver neoplasms—selective versus superselective method. J Clin Gastroenterol. 1994; 18 (2) 118-121
- 6 Hirakawa M, Iida M, Aoyagi K, Matsui T, Akagi K, Fujishima M. Gastroduodenal lesions after transcatheter arterial chemo-embolization in patients with hepatocellular carcinoma. Am J Gastroenterol. 1988; 83 (8) 837-840
- 7 Morante A, Romano M, Cuomo A et al.. Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma. Gastrointest Endosc. 2006; 63 (4) 718-720
- 8 Toyoda H, Fukuda Y, Nakano I et al.. Massive bleeding from a gastric erosion after transcatheter arterial chemoembolization for hepatocellular carcinoma in a patient with mild haemophilia A. Haemophilia. 2000; 6 (6) 688-692
- 9 Liu D M, Salem R, Bui J T et al.. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol. 2005; 16 (7) 911-935
- 10 Song S Y, Chung J W, Lim H G, Park J H. Nonhepatic arteries originating from the hepatic arteries: angiographic analysis in 250 patients. J Vasc Interv Radiol. 2006; 17 (3) 461-469
- 11 British Society of Gastroenterology Endoscopy Committee . Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut. 2002; 51 (Suppl 4) iv1-iv6
- 12 Leontiadis G I, Sharma V K, Howden C W. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2006; (1) CD002094
Siddharth A PadiaM.D.
Section of Vascular and Interventional Radiology, Department of Radiology, University of Washington Medical Center
1959 NE Pacific St., Box #357115, Seattle, WA 98195
eMail: spadia@uw.edu